Oncology Nutrition Market valued at US$ 1.69 Bn in 2022 and is expected to reach US$ 3.10 Bn by 2029, at a CAGR of 9.05 %during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report
Oncology Nutrition Market Dynamics:
Global oncology nutrition market has been increasing along with the rising incidence of many forms of cancers amongst people. Diagnosis of cancer is followed up by a series of tests and therapies to control the disease from getting the next stage. This has given a drive to the growth of the global market for oncology nutrition by necessitating regular intake of food. Cancer patients are at risk of suffering from disorders relating to incorrect nutrition due to their abysmal health condition. The deteriorating situation of cancer-affected persons also worsens their natural appetite, & therefore, the demand within the global oncology nutrition market has been escalating. A number of advancements in the domain of oncology have led to the growth of the global market and has given rise to numerous forms of nutrition for cancer patients. Based on cancer type, neck and head cancers are serving to drive major demand in the global oncology nutrition market. This is mostly on account of the tube feeding formulas for those afflicted with neck and head cancers. Such patients usually suffer from extreme conditions such as mucositis, dysgeusia, xerostomiaand nausea and vomiting which crimps nutritional uptake.Oncology Nutrition Market Segment Analysis:
In terms of distribution channel, hospitals segment held the largest market share in 2022. Due to the rise in cancer patients and to meet nutritional demand hospitals have indulged in providing proper meals to patients which in turn is driving the growth of the segment. Region-wise, North America accounted for the largest share of oncology nutrition market. However, the APAC region is expected to witness the highest CAGR during the forecast period. Growing in this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, increasing healthcare spending, large population base, and rapid improvements in the health insurance sector. Major players operating in market globally. The B. Braun a pharmaceutical company and one of the key players in the oncology nutrition market has officially opened five new and enhanced production plants also administrative buildings in Penang, Malaysia recently with state-of-the-art facilities determined mostly to protect and improve the health of the people in Malaysia and around the globe. In 2019, Nestlé S.A. was the second-largest player in the oncology nutrition market. The company is one of the leading manufacturers of enteral feeding formulas and supplies its products directly to customers as well as institutions, wholesalers, retailers, and healthcare facilities. The company’s nutritional products range aids address a wide area of health conditions-from pediatric allergies to inborn errors of metabolism as well as from obesity to malnutrition amongst the elderly. Its strong product contribution is attributable to the production capacity of almost a billion science-based nutritional solutions per year across its portfolio. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Oncology Nutrition Market. Oncology Nutrition Market, Key Highlights: 1. Global Oncology Nutrition Market analysis and forecast, in terms of value. 2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Oncology Nutrition Market 3. Global Oncology Nutrition Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. 4. Global Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. 5. Global Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. 6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. 7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Oncology Nutrition Market are also profiled.Oncology Nutrition Market Scope: Inquire before buying
Global Oncology Nutrition Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.69 Bn. Forecast Period 2023 to 2029 CAGR: 9.05% Market Size in 2029: US $ 3.10 Bn. Segments Covered: by Cancer Type Head and Neck Cancers Stomach and Gastrointestinal Cancers Liver Cancer Pancreatic Cancer Esophageal Cancer Lung Cancer Breast Cancer Blood Cancer Others by Distribution Channel Hospitals Retail Pharmacies Online Pharmacies Oncology Nutrition Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players:
1. Danone 2. Fresenius Kabi AG 3. B.BraunMelsungen AG 4. Mead Johnson Nutrition Company 5. Hormel Foods 6. Meiji Holdings 7. Victus 8. Global Health Products 9. Abbott Laboratories 10.Nestlé S.A. 11.Abbott Laboratories 12.Aceto 13.Baxter International 14.BioSig Technologies 15.FMC Corporation 16.Hansen Medical 17.Hormel Foods 18.Mead Johnson Nutrition Company Frequently Asked Questions: 1. Which region has the largest share in Global Market? Ans: North America region holds the highest share in 2022. 2. What is the growth rate of Global Oncology Nutrition Market? Ans: The Global Market is growing at a CAGR of 9.05% during forecasting period 2023-2029. 3. What is scope of the Global Oncology Nutrition market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Oncology Nutrition market? Ans: The important key players in the Global Market are – Danone, Fresenius Kabi AG, B.BraunMelsungen AG, Mead Johnson Nutrition Company, Hormel Foods, Meiji Holdings, Victus, Global Health Products, Abbott Laboratories, Nestlé S.A., Abbott Laboratories, Aceto, Baxter International, BioSig Technologies, FMC Corporation, Hansen Medical, and Hormel Foods. 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
Global Oncology Nutrition Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary : Global Oncology Nutrition Market Size, by Market Value(US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends in Global Oncology Nutrition Market 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Oncology Nutrition Market Analysis and Forecast 6.1. Global Oncology Nutrition Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Oncology Nutrition Market Analysis and Forecast, by Distribution Channel 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Oncology Nutrition Market Value Share Analysis, by Distribution Channel 7.4. Global Oncology Nutrition Market Size (US$ Bn) Forecast, by Distribution Channel 7.5. Global Oncology Nutrition Market Analysis, by Distribution Channel 7.6. Global Oncology Nutrition Market Attractiveness Analysis, by Distribution Channel 8. Global Oncology Nutrition Market Analysis and Forecast, by Cancer Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Oncology Nutrition Market Value Share Analysis, by Cancer Type 8.4. Global Oncology Nutrition Market Size (US$ Bn) Forecast, by Cancer Type 8.5. Global Oncology Nutrition Market Analysis, by Cancer Type 8.6. Global Oncology Nutrition Market Attractiveness Analysis, by Cancer Type 9. Global Oncology Nutrition Market Analysis, by Region 9.1. Global Oncology Nutrition Market Value Share Analysis, by Region 9.2. Global Oncology Nutrition Market Size (US$ Bn) Forecast, by Region 9.3. Global Oncology Nutrition Market Attractiveness Analysis, by Region 10. North America Oncology Nutrition Market Analysis 10.1. Key Findings 10.2. North America Oncology Nutrition Market Overview 10.3. North America Oncology Nutrition Market Value Share Analysis, by Distribution Channel 10.4. North America Oncology Nutrition Market Forecast, by Distribution Channel 10.4.1. Hospitals 10.4.2. Retail Pharmacies 10.4.3. Online Pharmacies 10.5. North America Oncology Nutrition Market Value Share Analysis, by Cancer Type 10.6. North America Oncology Nutrition Market Forecast, by Cancer Type 10.6.1. Head and Neck Cancers 10.6.2. Stomach and Gastrointestinal Cancers 10.6.3. Liver Cancer 10.6.4. Pancreatic Cancer 10.6.5. Esophageal Cancer 10.6.6. Lung Cancer 10.6.7. Breast Cancer 10.6.8. Blood Cancer 10.6.9. Others 10.7. North America Oncology Nutrition Market Value Share Analysis, by Country 10.8. North America Oncology Nutrition Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Oncology Nutrition Market Analysis, by Country 10.10. U.S. Oncology Nutrition Market Forecast, by Distribution Channel 10.10.1. Hospitals 10.10.2. Retail Pharmacies 10.10.3. Other 10.11. U.S. Oncology Nutrition Market Forecast, by Cancer Type 10.11.1. Head and Neck Cancers 10.11.2. Stomach and Gastrointestinal Cancers 10.11.3. Liver Cancer 10.11.4. Pancreatic Cancer 10.11.5. Esophageal Cancer 10.11.6. Lung Cancer 10.11.7. Breast Cancer 10.11.8. Blood Cancer 10.11.9. Others 10.12. Canada Oncology Nutrition Market Forecast, by Distribution Channel 10.12.1. Hospitals 10.12.2. Retail Pharmacies 10.12.3. Other 10.13. Canada Oncology Nutrition Market Forecast, by Cancer Type 10.13.1. Head and Neck Cancers 10.13.2. Stomach and Gastrointestinal Cancers 10.13.3. Liver Cancer 10.13.4. Pancreatic Cancer 10.13.5. Esophageal Cancer 10.13.6. Lung Cancer 10.13.7. Breast Cancer 10.13.8. Blood Cancer 10.13.9. Others 10.14. North America Oncology Nutrition Market Attractiveness Analysis 10.14.1. By Distribution Channel 10.14.2. By Cancer Type 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Oncology Nutrition Market Analysis 11.1. Key Findings 11.2. Europe Oncology Nutrition Market Overview 11.3. Europe Oncology Nutrition Market Value Share Analysis, by Distribution Channel 11.4. Europe Oncology Nutrition Market Forecast, by Distribution Channel 11.4.1. Hospitals 11.4.2. Retail Pharmacies 11.4.3. Other 11.5. Europe Oncology Nutrition Market Value Share Analysis, by Cancer Type 11.6. Europe Oncology Nutrition Market Forecast, by Cancer Type 11.6.1. Head and Neck Cancers 11.6.2. Stomach and Gastrointestinal Cancers 11.6.3. Liver Cancer 11.6.4. Pancreatic Cancer 11.6.5. Esophageal Cancer 11.6.6. Lung Cancer 11.6.7. Breast Cancer 11.6.8. Blood Cancer 11.6.9. Others 11.6.10. Europe Oncology Nutrition Market Value Share Analysis, by Country 11.7. Europe Oncology Nutrition Market Forecast, by Country 11.7.1. Germany 11.7.2. U.K. 11.7.3. France 11.7.4. Italy 11.7.5. Spain 11.7.6. Rest of Europe 11.8. Europe Oncology Nutrition Market Analysis, by Country 11.9. Germany Oncology Nutrition Market Forecast, by Distribution Channel 11.9.1. Hospitals 11.9.2. Retail Pharmacies 11.9.3. Other 11.10. Germany Oncology Nutrition Market Forecast, by Cancer Type 11.10.1. Head and Neck Cancers 11.10.2. Stomach and Gastrointestinal Cancers 11.10.3. Liver Cancer 11.10.4. Pancreatic Cancer 11.10.5. Esophageal Cancer 11.10.6. Lung Cancer 11.10.7. Breast Cancer 11.10.8. Blood Cancer 11.10.9. Others 11.11. U.K. Oncology Nutrition Market Forecast, by Distribution Channel 11.11.1. Hospitals 11.11.2. Retail Pharmacies 11.11.3. Other 11.12. U.K. Oncology Nutrition Market Forecast, by Cancer Type 11.12.1. Head and Neck Cancers 11.12.2. Stomach and Gastrointestinal Cancers 11.12.3. Liver Cancer 11.12.4. Pancreatic Cancer 11.12.5. Esophageal Cancer 11.12.6. Lung Cancer 11.12.7. Breast Cancer 11.12.8. Blood Cancer 11.12.9. Others 11.13. France Oncology Nutrition Market Forecast, by Distribution Channel 11.13.1. Hospitals 11.13.2. Retail Pharmacies 11.13.3. Other 11.14. France Oncology Nutrition Market Forecast, by Cancer Type 11.14.1. Head and Neck Cancers 11.14.2. Stomach and Gastrointestinal Cancers 11.14.3. Liver Cancer 11.14.4. Pancreatic Cancer 11.14.5. Esophageal Cancer 11.14.6. Lung Cancer 11.14.7. Breast Cancer 11.14.8. Blood Cancer 11.14.9. Others 11.15. Italy Oncology Nutrition Market Forecast, by Distribution Channel 11.15.1. Hospitals 11.15.2. Retail Pharmacies 11.15.3. Other 11.16. Italy Oncology Nutrition Market Forecast, by Cancer Type 11.16.1. Head and Neck Cancers 11.16.2. Stomach and Gastrointestinal Cancers 11.16.3. Liver Cancer 11.16.4. Pancreatic Cancer 11.16.5. Esophageal Cancer 11.16.6. Lung Cancer 11.16.7. Breast Cancer 11.16.8. Blood Cancer 11.16.9. Others 11.17. Spain Oncology Nutrition Market Forecast, by Distribution Channel 11.17.1. Hospitals 11.17.2. Retail Pharmacies 11.17.3. Other 11.18. Spain Oncology Nutrition Market Forecast, by Cancer Type 11.18.1. Head and Neck Cancers 11.18.2. Stomach and Gastrointestinal Cancers 11.18.3. Liver Cancer 11.18.4. Pancreatic Cancer 11.18.5. Esophageal Cancer 11.18.6. Lung Cancer 11.18.7. Breast Cancer 11.18.8. Blood Cancer 11.18.9. Others 11.19. Rest of Europe Oncology Nutrition Market Forecast, by Distribution Channel 11.19.1. Hospitals 11.19.2. Retail Pharmacies 11.19.3. Other 11.20. Rest of Europe Oncology Nutrition Market Forecast, by Cancer Type 11.20.1. Head and Neck Cancers 11.20.2. Stomach and Gastrointestinal Cancers 11.20.3. Liver Cancer 11.20.4. Pancreatic Cancer 11.20.5. Esophageal Cancer 11.20.6. Lung Cancer 11.20.7. Breast Cancer 11.20.8. Blood Cancer 11.20.9. Others 11.21. Europe Oncology Nutrition Market Attractiveness Analysis 11.21.1. By Distribution Channel 11.21.2. By Cancer Type 11.22. PEST Analysis 11.23. Key Trend 11.24. Key Development 12. Asia Pacific Oncology Nutrition Market Analysis 12.1. Key Findings 12.2. Asia Pacific Oncology Nutrition Market Overview 12.3. Asia Pacific Oncology Nutrition Market Value Share Analysis, by Distribution Channel 12.4. Asia Pacific Oncology Nutrition Market Forecast, by Distribution Channel 12.4.1. Hospitals 12.4.2. Retail Pharmacies 12.4.3. Other 12.5. Asia Pacific Oncology Nutrition Market Value Share Analysis, by Cancer Type 12.6. Asia Pacific Oncology Nutrition Market Forecast, by Cancer Type 12.6.1. Head and Neck Cancers 12.6.2. Stomach and Gastrointestinal Cancers 12.6.3. Liver Cancer 12.6.4. Pancreatic Cancer 12.6.5. Esophageal Cancer 12.6.6. Lung Cancer 12.6.7. Breast Cancer 12.6.8. Blood Cancer 12.6.9. Others 12.7. Asia Pacific Oncology Nutrition Market Value Share Analysis, by Country 12.8. Asia Pacific Oncology Nutrition Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Oncology Nutrition Market Analysis, by Country 12.10. China Oncology Nutrition Market Forecast, by Distribution Channel 12.10.1. Hospitals 12.10.2. Retail Pharmacies 12.10.3. Other 12.11. China Oncology Nutrition Market Forecast, by Cancer Type 12.11.1. Head and Neck Cancers 12.11.2. Stomach and Gastrointestinal Cancers 12.11.3. Liver Cancer 12.11.4. Pancreatic Cancer 12.11.5. Esophageal Cancer 12.11.6. Lung Cancer 12.11.7. Breast Cancer 12.11.8. Blood Cancer 12.11.9. Others 12.12. India Oncology Nutrition Market Forecast, by Distribution Channel 12.12.1. Hospitals 12.12.2. Retail Pharmacies 12.12.3. Other 12.13. India Oncology Nutrition Market Forecast, by Cancer Type 12.13.1. Head and Neck Cancers 12.13.2. Stomach and Gastrointestinal Cancers 12.13.3. Liver Cancer 12.13.4. Pancreatic Cancer 12.13.5. Esophageal Cancer 12.13.6. Lung Cancer 12.13.7. Breast Cancer 12.13.8. Blood Cancer 12.13.9. Others 12.14. Japan Oncology Nutrition Market Forecast, by Distribution Channel 12.14.1. Hospitals 12.14.2. Retail Pharmacies 12.14.3. Other 12.15. Japan Oncology Nutrition Market Forecast, by Cancer Type 12.15.1. Head and Neck Cancers 12.15.2. Stomach and Gastrointestinal Cancers 12.15.3. Liver Cancer 12.15.4. Pancreatic Cancer 12.15.5. Esophageal Cancer 12.15.6. Lung Cancer 12.15.7. Breast Cancer 12.15.8. Blood Cancer 12.15.9. Others 12.16. ASEAN Oncology Nutrition Market Forecast, by Distribution Channel 12.16.1. Hospitals 12.16.2. Retail Pharmacies 12.16.3. Other 12.17. ASEAN Oncology Nutrition Market Forecast, by Cancer Type 12.17.1. Head and Neck Cancers 12.17.2. Stomach and Gastrointestinal Cancers 12.17.3. Liver Cancer 12.17.4. Pancreatic Cancer 12.17.5. Esophageal Cancer 12.17.6. Lung Cancer 12.17.7. Breast Cancer 12.17.8. Blood Cancer 12.17.9. Others 12.18. Rest of Asia Pacific Oncology Nutrition Market Forecast, by Distribution Channel 12.18.1. Hospitals 12.18.2. Retail Pharmacies 12.18.3. Other 12.19. Rest of Asia Pacific Oncology Nutrition Market Forecast, by Cancer Type 12.19.1. Head and Neck Cancers 12.19.2. Stomach and Gastrointestinal Cancers 12.19.3. Liver Cancer 12.19.4. Pancreatic Cancer 12.19.5. Esophageal Cancer 12.19.6. Lung Cancer 12.19.7. Breast Cancer 12.19.8. Blood Cancer 12.19.9. Others 12.20. Asia Pacific Oncology Nutrition Market Attractiveness Analysis 12.20.1. By Distribution Channel 12.20.2. By Cancer Type 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Oncology Nutrition Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Oncology Nutrition Market Overview 13.3. Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Distribution Channel 13.4. Middle East & Africa Oncology Nutrition Market Forecast, by Distribution Channel 13.4.1. Hospitals 13.4.2. Retail Pharmacies 13.4.3. Other 13.5. Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Cancer Type 13.6. Middle East & Africa Oncology Nutrition Market Forecast, by Cancer Type 13.6.1. Head and Neck Cancers 13.6.2. Stomach and Gastrointestinal Cancers 13.6.3. Liver Cancer 13.6.4. Pancreatic Cancer 13.6.5. Esophageal Cancer 13.6.6. Lung Cancer 13.6.7. Breast Cancer 13.6.8. Blood Cancer 13.6.9. Others 13.7. Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Country 13.8. Middle East & Africa Oncology Nutrition Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Oncology Nutrition Market Analysis, by Country 13.10. GCC Oncology Nutrition Market Forecast, by Distribution Channel 13.10.1. Hospitals 13.10.2. Retail Pharmacies 13.10.3. Other 13.11. GCC Oncology Nutrition Market Forecast, by Cancer Type 13.11.1. Head and Neck Cancers 13.11.2. Stomach and Gastrointestinal Cancers 13.11.3. Liver Cancer 13.11.4. Pancreatic Cancer 13.11.5. Esophageal Cancer 13.11.6. Lung Cancer 13.11.7. Breast Cancer 13.11.8. Blood Cancer 13.11.9. Others 13.12. South Africa Oncology Nutrition Market Forecast, by Distribution Channel 13.12.1. Hospitals 13.12.2. Retail Pharmacies 13.12.3. Other 13.13. South Africa Oncology Nutrition Market Forecast, by Cancer Type 13.13.1. Head and Neck Cancers 13.13.2. Stomach and Gastrointestinal Cancers 13.13.3. Liver Cancer 13.13.4. Pancreatic Cancer 13.13.5. Esophageal Cancer 13.13.6. Lung Cancer 13.13.7. Breast Cancer 13.13.8. Blood Cancer 13.13.9. Others 13.14. Rest of Middle East & Africa Oncology Nutrition Market Forecast, by Distribution Channel 13.14.1. Hospitals 13.14.2. Retail Pharmacies 13.14.3. Other 13.15. Rest of Middle East & Africa Oncology Nutrition Market Forecast, by Cancer Type 13.15.1. Head and Neck Cancers 13.15.2. Stomach and Gastrointestinal Cancers 13.15.3. Liver Cancer 13.15.4. Pancreatic Cancer 13.15.5. Esophageal Cancer 13.15.6. Lung Cancer 13.15.7. Breast Cancer 13.15.8. Blood Cancer 13.15.9. Others 13.16. Middle East & Africa Oncology Nutrition Market Attractiveness Analysis 13.16.1. By Distribution Channel 13.16.2. By Cancer Type 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Oncology Nutrition Market Analysis 14.1. Key Findings 14.2. South America Oncology Nutrition Market Overview 14.3. South America Oncology Nutrition Market Value Share Analysis, by Distribution Channel 14.4. South America Oncology Nutrition Market Forecast, by Distribution Channel 14.4.1. Hospitals 14.4.2. Retail Pharmacies 14.4.3. Other 14.5. Others South America Oncology Nutrition Market Value Share Analysis, by Cancer Type 14.6. South America Oncology Nutrition Market Forecast, by Cancer Type 14.6.1. Head and Neck Cancers 14.6.2. Stomach and Gastrointestinal Cancers 14.6.3. Liver Cancer 14.6.4. Pancreatic Cancer 14.6.5. Esophageal Cancer 14.6.6. Lung Cancer 14.6.7. Breast Cancer 14.6.8. Blood Cancer 14.6.9. Others 14.7. South America Oncology Nutrition Market Value Share Analysis, by Country 14.8. South America Oncology Nutrition Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Oncology Nutrition Market Forecast, by Distribution Channel 14.9.1. Hospitals 14.9.2. Retail Pharmacies 14.9.3. Other 14.10. Brazil Oncology Nutrition Market Forecast, by Cancer Type 14.10.1. Head and Neck Cancers 14.10.2. Stomach and Gastrointestinal Cancers 14.10.3. Liver Cancer 14.10.4. Pancreatic Cancer 14.10.5. Esophageal Cancer 14.10.6. Lung Cancer 14.10.7. Breast Cancer 14.10.8. Blood Cancer 14.10.9. Others 14.11. Mexico Oncology Nutrition Market Forecast, by Distribution Channel 14.11.1. Hospitals 14.11.2. Retail Pharmacies 14.11.3. Other 14.12. Mexico Oncology Nutrition Market Forecast, by Cancer Type 14.12.1. Head and Neck Cancers 14.12.2. Stomach and Gastrointestinal Cancers 14.12.3. Liver Cancer 14.12.4. Pancreatic Cancer 14.12.5. Esophageal Cancer 14.12.6. Lung Cancer 14.12.7. Breast Cancer 14.12.8. Blood Cancer 14.12.9. Others 14.13. Rest of South America Oncology Nutrition Market Forecast, by Distribution Channel 14.13.1. Hospitals 14.13.2. Retail Pharmacies 14.13.3. Other 14.14. Rest of South America Oncology Nutrition Market Forecast, by Cancer Type 14.14.1. Head and Neck Cancers 14.14.2. Stomach and Gastrointestinal Cancers 14.14.3. Liver Cancer 14.14.4. Pancreatic Cancer 14.14.5. Esophageal Cancer 14.14.6. Lung Cancer 14.14.7. Breast Cancer 14.14.8. Blood Cancer 14.14.9. Others 14.15. South America Oncology Nutrition Market Attractiveness Analysis 14.15.1. By Distribution Channel 14.15.2. By Cancer Type 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Bench marking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Danone 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Fresenius Kabi AG 15.3.3. B.BraunMelsungen AG 15.3.4. Mead Johnson Nutrition Company 15.3.5. Hormel Foods 15.3.6. Meiji Holdings 15.3.7. Victus 15.3.8. Global Health Products 15.3.9. Abbott Laboratories 15.3.10. Nestlé S.A. 15.3.11. Abbott Laboratories 15.3.12. Aceto 15.3.13. Baxter International 15.3.14. BioSig Technologies 15.3.15. FMC Corporation 15.3.16. Hansen Medical 15.3.17. Hormel Foods 15.3.18. Mead Johnson Nutrition Company 16. Primary Key Insights